Core Viewpoint - Chow Tai Fook's mid-term performance for the fiscal year 2026 is solid, showcasing robust financial results and a strong underlying asset logic [1] Financial Data Summary - Shareholders' profit reached HKD 1.334 billion, a year-on-year increase of 15% [2] - The company declared an interim dividend of HKD 0.28 per share, marking a 3% increase compared to the same period last year, with a total dividend amount of HKD 1.27 billion, up 6% [2] - The net debt ratio decreased from 39% to 34%, and short-term debt significantly reduced from HKD 9.4 billion to HKD 6.8 billion, indicating positive financial optimization [2] - As of December 31, 2025, the total available liquid funds amounted to approximately HKD 31 billion [2] Business Segment Analysis - **Financial Services Segment**: This segment showed remarkable growth, with operating profit increasing by 19% to HKD 729 million. Chow Tai Fook Life Insurance's annualized premium surged by 48% to HKD 2.288 billion, and new business value grew by 39% to HKD 733 million [3] - **Logistics Segment**: Despite short-term pressures, the company is expanding its logistics portfolio, acquiring multiple properties to enhance cash flow and returns, with a total rental area of approximately 14.5 million square feet [4] - **Other Segments**: The road segment saw a 1% increase in operating profit to HKD 771 million, while the facilities management segment reported an 11% increase in EBITDA [4] Capital Operations and Market Outlook - The company issued low-interest exchangeable bonds worth HKD 2.218 billion in October 2025, showcasing innovative financing strategies [5] - Chow Tai Fook was re-included in the Hang Seng Composite Index and the Hong Kong Stock Connect, which is expected to enhance stock liquidity [5] Institutional Perspectives - Major banks have given positive ratings post-earnings release, with HSBC raising profit forecasts and maintaining a target price of HKD 10.1, while CITIC Lyon increased its target price to HKD 11.5, citing the potential for valuation re-evaluation [6][7] Conclusion - Chow Tai Fook's mid-term performance is characterized by strong financial results, with significant contributions from the financial services and road segments, alongside strategic expansion in logistics. The company has successfully reduced leverage, increased cash flow, and raised dividends, aligning with the global trend towards "heavy asset rental" models. The stock has appreciated nearly 18% year-to-date, outperforming the Hang Seng Index [9]

Core Viewpoint - The company, He Yu-B (02256.HK), announced that its subsidiary, Shanghai He Yu Biomedical Technology Co., Ltd., has received FDA designation for its self-developed selective oral small molecule FGFR2/3 inhibitor, ABSK061, for the treatment of achondroplasia, a rare pediatric disease [1] Group 1 - The FDA has granted the rare pediatric disease designation to ABSK061, indicating its potential significance in treating achondroplasia [1] - The drug is a high-selectivity, oral small molecule FGFR2/3 inhibitor, showcasing the company's innovative approach in drug development [1]

Group 1 - The company China Hongqiao (01378.HK) announced a board meeting scheduled for March 20, 2026, to consider and approve the release of its full-year results for the fiscal year ending December 31, 2025, and to propose a final dividend if applicable [1]

Group 1 - JPMorgan Chase & Co. reduced its holdings in Ganfeng Lithium (01772.HK) by selling 1.247 million shares at an average price of HKD 60.0492 per share, totaling approximately HKD 74.8894 million [1] - After the reduction, JPMorgan's total holdings in Ganfeng Lithium decreased to 27.743 million shares, representing a decline in ownership from 6.00% to 5.74% [1]

Core Viewpoint - BYD is exploring entry into competitive motorsports, including Formula 1 (F1) and endurance racing, to enhance its global appeal amid rapid overseas expansion and the shift towards hybrid engines in motorsports [1] Group 1 - BYD is evaluating multiple options to participate in events such as the World Endurance Championship, including the Le Mans 24 Hours race and F1 [1] - The company plans to achieve this goal by either forming its own racing team or through acquisitions [1] - A potential obstacle for BYD in entering F1 is the high cost, with a single season's expenses potentially reaching up to $500 million [1]

格隆汇3月10日丨根据联交所最新权益披露资料显示，2026年3月5日，康龙化成(03759.HK)遭JPMorgan Chase & Co.以每股均价18.1145港元减持好仓73.75万 股，涉资约1335.91万港元。 减持后，JPMorgan Chase & Co.最新持好仓数目为2141.55万股，持好仓比例由6.15%下降至5.94%。 | 麦格序號 | 大股東/董事/最高行政人員名 作出披露的 買入 / 賣出或涉及的 每股的平均價 | | | | | | 持有權益的股份數目 佔已發行的有關事件的日 相關法 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | 鳥 大 | 股份數目 | | | 精參閱上述*註 | 有投票權股期(日/月/ 份權益 | | | | | | | | | 份自分比 中) | | | | | | | | | 96 1 | | CS20260310E00182 | JPMorgan Chase & Co. | 1201(L) | | 737.481(L) | HKD 18.1145 | 21.415.472(L) | ...

格隆汇3月10日丨根据联交所最新权益披露资料显示，2026年3月6日，中国铝业(02600.HK)遭中信证券资产管理有限公司在场内以每股均价13.6635港元减持 1801.4万股，涉资约2.46亿港元。 减持后，中信证券资产管理有限公司最新持股数目为419,468,000股，持股比例由11.09%下降至10.64%。 | 股份代號: | 02600 | | --- | --- | | 上市法國名稱: | 中國鋁業股份有限公司 - H股 | | 日期 (日 / 月 / 年): | 10/02/2026 - 10/03/2026 | | 表格序號 | 大股東/董事/最高行政人員名 作出披露的 買入 / 賣出或涉及的 每股的平均價 | | | | 持有權益的股份數目 佔已發行的有關事件的日 相關法 | | --- | --- | --- | --- | --- | --- | | | 股份數目 | 原因 | | | 請參閱上述*註 有投票權股期(日/月/ 份權益 | | | | | | | 份自分比 细 | | CS20260310E00067 | 中信证券资产管理有限公司 | 1201(L) | 18.014. ...

Core Insights - The company is expected to see a revenue decline of 7-8% in 2025, with liquid milk stabilizing in H2 and double-digit growth in milk powder and cheese categories throughout the year [1][2] - The company plans to provision for impairment losses of 2.2-2.4 billion yuan, which is anticipated to allow the company to operate with a lighter burden as the raw milk cycle stabilizes [1][2] - The investment recommendation remains "Buy," with projected revenues for 2025-2027 at 82.21 billion, 85.01 billion, and 88.63 billion yuan, respectively, and net profits of 1.53 billion, 4.51 billion, and 5.39 billion yuan [1] Revenue and Profitability - The company expects total revenue in 2025 to decline to 81.6-82.5 billion yuan due to market demand pressures and intense competition, while operating cash flow remains stable [1] - Liquid milk revenue has shown a steady recovery since H2 2025, with fresh milk, milk powder, and cheese categories all achieving double-digit growth [1] - The company is focusing on product iteration and innovation, promoting diversified business development [1] Impairment and Cost Management - The company plans to provision for impairment losses on idle production facilities, receivables, and entrusted loans, totaling 2.2-2.4 billion yuan, with expected net profit for the year between 1.4-1.6 billion yuan, compared to 100 million yuan in the previous year [2] - Management optimization and cost control efforts are ongoing, with increased investment in R&D and digitalization to enhance operational efficiency [2] - The operating profit margin is expected to decline by 0.1-0.3 percentage points to 7.9-8.1% [2] Market Outlook - The raw milk price is stabilizing, with supply benefiting from a reduction in heifer stocking and diminished impact from imports, while demand is supported by the continuous release of processing capacity [2] - The company is expected to benefit from an improved competitive landscape and enhanced profitability from joint ventures as milk prices enter an upward cycle [2]

Core Viewpoint - China Resources Beer (00291.HK) is expected to report a profit of approximately 2.92 billion to 3.35 billion yuan for the fiscal year ending December 31, 2025, representing a year-on-year decrease of about 29.6% to 38.6% compared to the profit of approximately 4.76 billion yuan for the fiscal year ending December 31, 2024 [1] Group 1 - The decrease in profit is primarily attributed to an impairment of goodwill estimated between 2.79 billion to 2.97 billion yuan, which was recognized following the acquisition of a 55.19% stake in Guizhou Jinsha Jiaojiu Liquor Co., Ltd. on January 10, 2023 [1] - The impairment of goodwill is mainly due to weak demand in the liquor market, leading to a contraction in consumption scenarios and a reduction in consumer demand [1]

Core Viewpoint - Far East Horizon (03360.HK) announced that Liu Haifeng will no longer serve as a non-executive director and chairman of the Strategic and Investment Committee, as his term will expire on March 10, 2026 [1] Company Summary - Liu Haifeng's term as a non-executive director will end on March 10, 2026 [1] - Liu also held the position of chairman of the Strategic and Investment Committee [1]